High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

Citations Over TimeTop 1% of 2013 papers

Abstract

Somatic mutations activating telomerase reverse-trancriptase promoter were recently identified in several tumour types. Here we identify frequent similar mutations in human hepatocellular carcinomas (59%), cirrhotic preneoplastic macronodules (25%) and hepatocellular adenomas with malignant transformation in hepatocellular carcinomas (44%). In hepatocellular tumours, telomerase reverse-transcripase- and CTNNB1-activating mutations are significantly associated. Moreover, preliminary data suggest that telomerase reverse-trancriptase promoter mutations can increase the expression of telomerase transcript. In conclusion, telomerase reverse-trancriptase promoter mutation is the earliest recurrent genetic event identified in cirrhotic preneoplastic lesions so far and is also the most frequent genetic alteration in hepatocellular carcinomas, arising from both the cirrhotic or non-cirrhotic liver.

Related Papers

• → Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells(2001)196 cited
• → Differential regulation of telomerase activity by six telomerase subunits(2002)81 cited
• Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.(2006)
• → Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.(1999)46 cited
• Effect of newly identified hTERT-interacting proteins on telomerase activity(2013)